2021
DOI: 10.3390/ijms22083968
|View full text |Cite
|
Sign up to set email alerts
|

Rapamycin Alleviates 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced Aggravated Dermatitis in Mice with Imiquimod-Induced Psoriasis-Like Dermatitis by Inducing Autophagy

Abstract: Recently, the mTOR signaling has emerged as an important player in the pathogenesis of psoriasis. We previously found that 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced psoriatic skin inflammation was related to the inhibition of autophagy in keratinocytes. However, the effects and detailed molecular mechanisms of the mTOR inhibitor rapamycin and TCDD on psoriasis in vivo remain to be elucidated. In this study, we aimed to evaluate the effects of rapamycin and TCDD on skin lesions in imiquimod (IMQ)-induc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(17 citation statements)
references
References 61 publications
0
17
0
Order By: Relevance
“…In turn, activation of Nrf2/HO-1 by TGN also inhibits activation of NF-κB and STAT3 which are the key transcription factors in psoriasis pathogenesis and promote the skin defense system while reducing the expression of immune mediators and epidermal proliferation (Lee et al, 2020). Further proving our subject, 2,3,7,8tetrachlorodibenzo-p-dioxin (TCDD) aggravated IMQ-induced psoriasis by increasing the expression of phosphorylated NF-κB p65 and inhibiting the antioxidant marker Nrf2 (Kim et al, 2021). These studies have provided a novel and clinically meaningful perspective on the pathogenesis and therapeutic targets of psoriasis in the world.…”
Section: Imiquimod (Imq)-induced Psoriasismentioning
confidence: 63%
“…In turn, activation of Nrf2/HO-1 by TGN also inhibits activation of NF-κB and STAT3 which are the key transcription factors in psoriasis pathogenesis and promote the skin defense system while reducing the expression of immune mediators and epidermal proliferation (Lee et al, 2020). Further proving our subject, 2,3,7,8tetrachlorodibenzo-p-dioxin (TCDD) aggravated IMQ-induced psoriasis by increasing the expression of phosphorylated NF-κB p65 and inhibiting the antioxidant marker Nrf2 (Kim et al, 2021). These studies have provided a novel and clinically meaningful perspective on the pathogenesis and therapeutic targets of psoriasis in the world.…”
Section: Imiquimod (Imq)-induced Psoriasismentioning
confidence: 63%
“…It is known that metformin and rapamycin treatments are able to extend the healthspan and lifespan of mice [ 216 , 217 ]. Interestingly, there is clear evidence that metformin and rapamycin can suppress AhR signaling in different models [ 218 , 219 ]. It seems that autophagy is involved in these results since both metformin and rapamycin are potent inducers of autophagy and it is known that autophagy is an important regulator of the aging process [ 52 , 107 ].…”
Section: Anti-aging Therapeutic Treatments Suppress Ahr Signalingmentioning
confidence: 99%
“…The mTOR inhibitor rapamycin is associated with the regulation of autophagy [ 109 ] and the dysfunction of which could contribute to the pathogenesis of psoriasis [ 110 ]. Rapamycin restored suppressed autophagy and increased AHR expression by PAH, 2,3,7,8-tetrachlorodibenzo-p-dioxin, in mouse psoriasis skin [ 111 ]. Galangin, an active flavonoid extracted from Alpinia officinarum , Alpina galanga , and propolis, downregulated the NF-κB signaling pathway in mouse psoriatic skin [ 112 ].…”
Section: Nrf2 and Psoriasismentioning
confidence: 99%